Status:
UNKNOWN
Electrical Muscle Stimulation in Congestive Heart Failure
Lead Sponsor:
Kantonsspital Olten
Conditions:
Congestive Heart Failure
Electric Muscle Stimulation
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
This trial is to evaluate two types of electrical muscle Stimulation (EMS) stimulation (low intensity "conventional stimulation" vs. high intensity "Russian" stimulation) of legs in comparison with a ...
Detailed Description
BACKGROUND: Congestive heart failure (CHF) is increasingly prevalent worldwide and is associated with significant morbidity and mortality. Poor exercise capacity is well known as a risk factor for po...
Eligibility Criteria
Inclusion
- age ≥ 60 years
- hospitalized due to heart failure
- left ventricular ejection fraction ≤ 40%
- NYHA class II to IV
- willingness to complete the 6-week EMS training programme
- tolerability of the electrical stimulation
- provision of informed consent
Exclusion
- severe neuromuscular or oncologic diseases with inability to perform exercise testing and EMS training
- inotropic intravenous agents used (≤10 days)
- implanted pacemaker/ICD
- unstable angina
- severe uncontrolled arrhythmias
- patients with severe pulmonary limitation (Tiffeneau ratio \<70%, or vital capacity \<70% of predicted value)
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03793647
Start Date
April 1 2019
End Date
December 30 2021
Last Update
April 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kantonsspital Olten
Olten, Switzerland, 4600